Evidence of blood–brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder
Annals of Clinical and Translational Neurology · 2025
DOI: 10.1002/acn3.52299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Jonathan D Santoro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Down Syndrome, Blood-Brain Barrier, Immunoglobulins, Neuroinflammatory Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Child Health and Human Development, NHLBI NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Objectives
This study sought to evaluate proteomic, metabolomic, and immune signatures in the cerebrospinal fluid of individuals with Down Syndrome Regression Disorder (DSRD).
Methods
A prospective case–control study comparing proteomic, metabolomic, and immune profiles in individuals with DSRD was performed. Samples were obtained from a biorepository of affected individuals and compared to clinically available data and previously obtained neurodiagnostic studies. Individuals with DSRD were compared to individuals with established neuroinflammatory conditions (e.g., multiple sclerosis), and neurotypical controls undergoing a lumbar puncture for headaches. Samples underwent high‐throughput proteomic, metabolomic, and immune marker profiling. Data was compared across groups and clinical phenotypes. Gene set enrichment analysis and pathway analyses were utilized to analyze the data.
Results
In total, 34 individuals with DSRD, 22 neuroinflammatory controls, and 27 neurotypical controls were enrolled in the study. We observed a highly significant concordance in dysregulated proteomics signatures in DSRD and neuroinflammatory controls versus healthy controls, most prominently upregulation of many immunoglobulin sequences. In addition, individuals with DSRD displayed strong upregulation of liver‐derived plasma proteins and erythrocyte proteins in the CSF, indicating poor blood–brain barrier integrity. The immune marker profile of DSRD is clearly similar to other neuroimmunological conditions, including strong elevation of MIP3‐α, eotaxin, and IFN‐γ.
Interpretation
Individuals with DSRD have unique CSF proteomic and metabolomic signatures consistent with neuroinflammation and increased blood–brain barrier permeability. The CSF of individuals with DSRD was more comparable to individuals with neuroinflammatory disorders than neurotypical controls, indicating the potential for an immune etiology of disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Neurology, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
- Department of Neurology, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
- Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
- Division of Developmental Pediatrics, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
ORCID-Profile: Jonathan D Santoro
Förderung
- National Institute of Child Health and Human Development
- NHLBI NIH HHS
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Heart, Lung, and Blood Institute
Zitieren
APA
Santoro, J. D., Eduthan, N. P., Khoshnood, M. M., Jafarpour, S., Boyd, N. K., Vogel, B. N., Nguyen, L., Kazerooni, L., Britton, E., Lyford, H. R., Galbraith, M. D., Rachubinski, A. L., & Espinosa, J. M. (2025). Evidence of blood–brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52299
Vancouver
Santoro JD, Eduthan NP, Khoshnood MM, Jafarpour S, Boyd NK, Vogel BN, et al. Evidence of blood–brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.52299
BibTeX
@article{Santoro2025,
author = {Santoro, Jonathan D and Eduthan, Neetha Paul and Khoshnood, Mellad M and Jafarpour, Saba and Boyd, Natalie K and Vogel, Benjamin N and Nguyen, Lina and Kazerooni, Lilia and Britton, Eleanor and Lyford, Hannah R and Galbraith, Matthew D and Rachubinski, Angela L and Espinosa, Joaquin M},
title = {Evidence of blood–brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
doi = {10.1002/acn3.52299}
}
EUVIMED